Adage Capital Partners GP »

An2 Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 313k 3.25
2023-09-30 $15M 906k 16.08

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding An2 Therapeutics

RA Capital Management
Octagon Capital Advisors
Frazier Life Sciences Management
TCG Crossover Management
Citadel Advisors
Henderson Group
Vanguard Group
Millennium Management
Adage Capital Partners GP
BlackRock
Goldman Sachs Group
Ghost Tree Capital
Geode Capital Management
Two Sigma Advisers
Walleye Trading Advisors

View all funds holding An2 Therapeutics